Report Finds Significant Industry Affiliation in IGWG ‘NGO’ Comments 08/11/2007 by Kaitlin Mara for Intellectual Property Watch Leave a Comment By Kaitlin Mara for Intellectual Property Watch As negotiators gather at the United Nations this week in Geneva to seek ways to boost innovation on neglected diseases disproportionately affecting poor people, a new study was released showing that commentators at the negotiation’s public hearing came primarily from organisations affiliated in some way with the pharmaceutical […]
Le Conseil sur les ADPIC se penche sur les questions relatives aux PMA, à la santé, la biodiversité, et la mise en application 07/11/2007 by Catherine Saez, Intellectual Property Watch Leave a Comment Par William New Le Comité sur les droits de propriété intellectuelle de l’Organisation Mondiale du Commerce (OMC) a accordé en octobre un délai supplémentaire de deux ans aux pays pour ratifier un accord de santé publique permettant aux pays d’importer plus facilement des médicaments moins chers. Il a également entrepris d’évaluer les besoins pour les […]
Acuerdo comercial entre EE.UU. y Perú: primera puesta a prueba de las disposiciones renegociadas sobre PI 07/11/2007 by William New, Intellectual Property Watch Leave a Comment Por Martin Vaughan para Intellectual Property Watch La Cámara de Representantes de los Estados Unidos se dispone a aprobar esta semana el acuerdo de libre comercio entre los EE.UU. y Perú, en la primera puesta a prueba de la nueva “política comercial bipartidista”, que dio lugar a la renegociación de los acuerdos comerciales con Colombia, […]
El Consejo de los Aspectos de los Derechos de Propiedad Intelectual relacionados con el Comercio aborda el tema de los países en vías de desarrollo, la salud, la biodiversidad y las cuestiones de aplicación 06/11/2007 by Catherine Saez, Intellectual Property Watch Leave a Comment Por William New El comité de los derechos de la propiedad intelectual de la Organización Mundial del Comercio amplió en octubre el plazo a dos años para que los países ratifiquen un acuerdo de salud pública que facilite la importación de medicamentos a bajos costes. También abordó el tema de la identificación de las necesidades […]
US-Peru Trade Deal The First Test Of Renegotiated IP Provisions 05/11/2007 by Martin Vaughan for Intellectual Property Watch 1 Comment By Martin Vaughan for Intellectual Property Watch The United States House of Representatives is poised to pass the US-Peru free trade agreement this week, in the first test of the new “bipartisan trade policy” that led to the renegotiation of trade agreements with Colombia, Panama, Peru and South Korea. The Peru pact includes new provisions […]
Thailand: Latest Talks With Patent Owners of Cancer Drugs Show Positive Results 05/11/2007 by Sinfah Tunsarawuth for Intellectual Property Watch Leave a Comment By Sinfah Tunsarawuth for Intellectual Property Watch BANGKOK – Thai government officials said the latest round of negotiations with patent owners of cancer treatment drugs showed positive results with drug companies agreeing to make their supplies more available to certain cancer patients. But they stopped short of saying that the government would now have no […]
New USPTO Rules Blocked; EU Views New Patent Litigation Proposal 05/11/2007 by Dugie Standeford for Intellectual Property Watch Leave a Comment By Dugie Standeford for Intellectual Property Watch A US federal court in Virginia has temporarily blocked the US Patent and Trademark Office (USPTO) from implementing controversial new rules governing patent application continuations. The rules, set to come into effect on 1 November, sparked strong opposition from many patent attorneys who argued that capping the number of patent claims and continuing applications would harm inventors seeking to protect intellectual property rights in the fast-moving high-technology sector (IPW, Patent Policy, 10 September 2007). Separately, Portugal, which holds the EU presidency, floated a revised proposal for a European patent litigation system. The draft, although seen by critics as much improved over earlier versions, leaves several key issues unresolved, said Kevin Mooney, a UK attorney with Simmons & Simmons and president of the European Patent Lawyers Association (EPLAW).
Thailand: 20 More Drugs In Pipeline For Possible Compulsory Licences 02/11/2007 by Sinfah Tunsarawuth for Intellectual Property Watch Leave a Comment By Sinfah Tunsarawuth for Intellectual Property Watch BANGKOK – Thailand has in its pipeline about 20 more items of various patented drugs that could be candidates for compulsory licences, allowing the government to exercise its right over the patent owners to cut prices and make the medicines more available to the public, a senior Thai […]
WTO Biodiversity Amendment Backed; EU Seeks ‘New Thinking’ On GIs 26/10/2007 by William New, Intellectual Property Watch Leave a Comment By William New A proposal to amend the World Trade Organization rules on intellectual property rights to require the disclosure of the origin of genetic resources in patent applications gained significant new support Wednesday when 50 least-developed countries signed on. The additional support for the proposed amendment came at the 23-24 October meeting of the […]
Parliament Paves Way for EU Adoption Of WTO Health Amendment 24/10/2007 by David Cronin for Intellectual Property Watch 1 Comment By David Cronin for Intellectual Property Watch BRUSSELS – The European Union has pledged not to include any intellectual property provisions that would curb access to medicines in a series of free trade agreements it is negotiating with least-developed countries. The commitment has been given as part of a deal struck between the EU’s three […]